SUPPRESSION OF HLA‐SPECIFIC ALLOANTIBODIES BY HIGH‐DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIg): A POTENTIAL TOOL FOR TRANSPLANTATION OF IMMUNIZED PATIENTS